Fig. 1. Efficacy data for study population.
(A) Swimmer’s plot showing time on study, off-treatment reason, current status and time of response if applicable; the arrow indicates patients still on study; white circle, time of response; blue circle, time of discontinuation due to toxicity. (B) Plot showing magnitude of change in target lesion sum over time as per RECIST; patients evaluable in target lesions not treated by RFA/TACE.